ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2009

Jun 5, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2009-06-03

Reporting Person: H.I.G. ONCOGENEX, INC. (10% Owner)
Reporting Person: H.I.G. KEY CORP (10% Owner)
Reporting Person: H.I.G. HORIZON CORP (10% Owner)
Reporting Person: MNAYMNEH SAMI (10% Owner)
Reporting Person: TAMER ANTHONY (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-06-03	Common Stock	S	100000	$20.7861	Disposed	545512	Direct

Footnotes

F1: The shares to which this report relates are owned directly by H.I.G. Horizon Corporation, which is a wholly-owned subsidiary of H.I.G. Key Corporation, which is a wholly-owned subsidiary of H.I.G. Oncogenex, Inc. Sami W. Manaymneh and Anthony Tamer are the shareholders of H.I.G.-GP II, Inc., the general partner and managing member, respectively, of the two entities which are indirectly the majority shareholders of H.I.G. Oncogenex, Inc. H.I.G. Key Corporation, H.I.G. Oncogenex, Inc. and Messrs. Mnaymneh and Tamer may be deemed to be the indirect beneficial owners of these securities, but disclaim beneficial ownership in the securities, except to the extent of its or his pecuniary interest in such securities.